A population and family study of CYP1A2 using caffeine urinary metabolites

This publication has 35 references indexed in Scilit:

• Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
  Pharmacogenetics, 1992
• Identification of the Ah Receptor Nuclear Translocator Protein (Arnt) as a Component of the DNA Binding Form of the Ah Receptor
  Science, 1992
• Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1
  Pharmacogenetics, 1992
• Diurnal Effect on Caffeine Clearance
  The Journal of Clinical Pharmacology, 1992
• Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine
  Carcinogenesis: Integrative Cancer Research, 1992
• Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin
  Pharmacogenetics, 1991
• Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
  Chemical Research in Toxicology, 1991
• Cloning of a Factor Required for Activity of the Ah (Dioxin) Receptor
  Science, 1991
• Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study.
  American Journal of Public Health, 1990
• Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer.
  Proceedings of the National Academy of Sciences, 1988